Abstract
MUCH is now known about the body's metabolism of cyanide within a pattern of normal physiology. The conversion of cyanide to thiocyanate was first demonstrated in 1894 1 and the enzymatic nature of this reaction was investigated in 1933 2). The enzyme system was named ‘rhodanese’ and it has been found to be specific for free cyanide without action on organically bound cyano groups. This property indicates that the excretion of thiocyanates after the administration of organic nitriles results not from a direct action on the nitrile itself, but from hydrogen cyanide which had first been removed from the nitrile molecule by another mechanism. Although this rhodanese/thiocyanate excretory pathway is considered to be the primary factor in the detoxification of cyanide there undoubtedly exist other pathways by which this may be mediated or assisted3. These implicate one-carbon compounds and also reveal that the radiocarbon of Na14CN appears in the methyl groups of choline and methionine and in the ureide carbons of allantoin. Some of it also finds its way into the cyano group of cyanocobalamin. It is known that hydroxocobalamin takes up cyanide avidly to form cyanocobalamin and can protect the experimental animal against lethal doses4. Latterly, a further pathway in the detoxification of cyanide has been implicated5. This shows that cyanide can combine with cystine in vitro to form 2-iminothiazolidine-4-carboxylic acid and that the formation of this acid also occurs in vivo. On injection of potassium cyanide subcutaneously into rats, the acid can be isolated from the urine in quantities corresponding to 15 per cent of the dose, although the main excretory product (80 per cent of the dose) is thiocyanate.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lang, S., Arch. Exp. Path. Pharmak., 34, 247 (1894).
Lang, K., Biochem. Z., 259, 243 (1933).
Boxer, G. E., and Rickards, J. C., Arch. Biochem., 39, 7 (1952).
Mushett, C. W., Kelley, K. L., Boxer, G. E., and Rickards, J. C., Proc. Soc. Exp. Biol. and Med., 81, 234 (1952).
Wood, J. L., and Cooley, S. L., J. Biol. Chem., 218, 449 (1956).
Hurst, E. W., Austral. J. Exp. Biol. and Med. Sci., 20, 297 (1942).
Lumsden, C. E., J. Neurol. Neurosurg. Psychiat., 13, 1 (1950).
van Houten, W. H., and Friede, R. L., Exp. Neurol., 4, 402 (1961).
Smith, A. D. M., Duckett, S., and Waters, A. H., Nature, 200, 179 (1963).
Smith, A. D. M., Lancet, i, 1001 (1961).
Smith, A. D. M., Lancet, ii, 668 (1964).
Wyndham, R. A., Austral. J. Exp. Biol. and Med. Sci., 19, 243 (1941).
Aldridge, W. N., Analyst, 70, 474 (1945).
Ford, D. H., Hirschman, A., Rhines, R., and Zimberg, S., Exp. Neurol., 4, 444 (1961).
Braekkan, O., Njaa, L. R., and Utne, F., Acta Pharm, Tox, Kbh, 13, 228 (1957).
Rose, C. L., Harris, P. N., and Chen, K. K., Proc. Soc. Exp. Biol. N.Y., 87, 832 (1954).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
SMITH, A., FOULKES, M. Cyanide Excretion in the Rat. Nature 209, 919–920 (1966). https://doi.org/10.1038/209919a0
Issue Date:
DOI: https://doi.org/10.1038/209919a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.